The weekly litigation news digest is live. Subscribe now

IP Verse

Shire Viropharma competitive analysis

Loading summary...

Latest patents of Shire Viropharma opposed by its competitors

Explore Shire Viropharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3071219
Nov 14, 2018Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase Inhibitor1
EP2968434
Jun 28, 2017C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor Deficency2

Latest PTAB cases involving Shire Viropharma

Discover the latest PTAB cases involving Shire Viropharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 17, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Shire Viropharma

IPR2019-00459Dec 21, 2018CSL BEHRINGSHIRE VIROPHARMA INCORPORATEDInstitution Denied
IPR2017-01512May 31, 2017CSL BEHRINGSHIRE VIROPHARMA INCORPORATEDInstitution Denied

Peer Comparison New

IP litigation analysis comparing Shire Viropharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SHIRE VIROPHARMA - 3 - -
CSL BEHRING394 -
CSL INNOVATION1 - - -
OCTAPHARMA78 - -